PAX5 and breast carcinoma: In parallel, Benzina et al. (2017) have shown that PAX5 not only promotes breast cancer epithelial identity but also induces MET of aggressive breast cancer cells through direct transactivation of E-cadherin, a pivotal regulator of epithelialization [114].